mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.003 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |